Universal Standing Order for Naloxone [For Pharmacist CPE]

Overview: This training module will provide a standardized, evidence-based curriculum to train and inform pharmacists in hospital, community, and chain pharmacy settings on how to implement and sustain a naloxone co-dispensing program in their practice. This program serves as an adjunct to a co-prescribing program designed for physicians

Agenda:

1. Introduction
2. Brief history of the Opioid Crisis Background information on Naloxone
3. What steps should be taken when Implementing a Naloxone Co-Dispensing Program
4. Examples of how to follow these steps in a hospital setting, which we will call Jersey Care , and within a small independent community pharmacy setting, which we will refer to as Rxtra Care
5. Considerations for different practice settings
6. Policy progress in New Jersey to date
7. Sample implementation timeline
8. Summary of our findings

Learning Objectives:

1. Demonstrate the importance of co-dispensing naloxone for patients with chronic pain and substance use disorder (SUD) in our current healthcare landscape
2. Learn to examine legal considerations for co-dispensing and co-prescribing naloxone in New Jersey along with national, state, and organizational recommendations
3. Learn how to implement a naloxone co-dispensing program across various settings when approved by administration 
4. Interpret the strategies and barriers to implementing a successful naloxone co-dispensing program in your practice
5. Utilize various processes for mitigating stigma reduction in naloxone co-dispensing initiatives
6. Identify the process of using implementation science to establish a framework for a successful naloxone co-dispensing program

Certificate of Completion: Participants will receive their certificate of completion upon the completion of their pre and post assessment in the course.

Available credit: UAN: 0136-999-21-029-H08-P and the CEU: 0.2

Credit is awarded after successful completion of required course components, passing tests and submitting evaluations. Providing your NABP number and MMDD of birth during registration is required to upload credit, within 60 days of verification of successful course completion, to CPE Monitor. Please review the additional accreditation information provided at the beginning of the course nodules.

Audience: Pharmacists

Activity type: Knowledge-based activity

Enduring Course will be open: November 1, 2021, through December 2023.

Hearing Impaired Registrants: This enduring course contains closed captioning.